Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism Apr 9, 2024 8:11am EDT
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update Mar 29, 2024 8:21am EDT